Markets

Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug

Oct 14, 2026 · 01:34 PM ET· updated 1h ago

Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.

Why It Matters

Eton got the rights to sell a seizure rescue medicine in the U.S. starting in 2027. When one company gets exclusive rights to sell a medicine, it can mean steady future income and shows confidence in the drug's value.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

AQST4.59

-0.08 (-1.71%)

ETON52.96

-0.37 (-0.69%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.